(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 4.03% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.33%.
Baxter International's revenue in 2025 is $10,887,000,000.On average, 19 Wall Street analysts forecast BAX's revenue for 2025 to be $5,867,093,379,803, with the lowest BAX revenue forecast at $5,663,699,439,647, and the highest BAX revenue forecast at $6,128,012,878,791. On average, 19 Wall Street analysts forecast BAX's revenue for 2026 to be $6,088,977,678,155, with the lowest BAX revenue forecast at $5,812,135,926,276, and the highest BAX revenue forecast at $6,386,364,272,474.
In 2027, BAX is forecast to generate $6,291,344,376,189 in revenue, with the lowest revenue forecast at $5,827,544,558,106 and the highest revenue forecast at $6,662,692,403,292.